• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Recent Advances in the Study of 3-iodo-6-methyl-1H-indole (CAS: 1360939-00-9) in Chemical Biology and Pharmaceutical Research

The compound 3-iodo-6-methyl-1H-indole (CAS: 1360939-00-9) has recently emerged as a molecule of significant interest in chemical biology and pharmaceutical research. This heterocyclic aromatic compound, characterized by its indole core structure with iodine and methyl substituents, has demonstrated promising potential in various applications, including medicinal chemistry, drug discovery, and chemical biology probes. Recent studies have focused on its unique physicochemical properties, synthetic accessibility, and biological activities, making it a valuable scaffold for further investigation.

In the context of medicinal chemistry, 3-iodo-6-methyl-1H-indole has been explored as a building block for the development of novel therapeutic agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility as a precursor for the synthesis of potent kinase inhibitors. The iodine atom at the 3-position serves as an excellent handle for further functionalization through transition metal-catalyzed cross-coupling reactions, enabling rapid diversification of the indole scaffold. Researchers have successfully employed this compound in palladium-catalyzed Sonogashira and Suzuki-Miyaura couplings to generate libraries of derivatives with enhanced biological activities.

The biological activity profile of 3-iodo-6-methyl-1H-indole and its derivatives has been the subject of several recent investigations. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that certain derivatives exhibit significant anti-inflammatory activity through modulation of the NF-κB signaling pathway. The methyl group at the 6-position appears to play a crucial role in the compound's ability to interact with biological targets, as demonstrated by structure-activity relationship (SAR) studies. Molecular docking simulations suggest that this substitution pattern allows for optimal hydrophobic interactions with protein binding pockets.

From a chemical biology perspective, 3-iodo-6-methyl-1H-indole has shown promise as a versatile probe for studying protein-ligand interactions. Recent work published in ACS Chemical Biology (2024) highlighted its use in photoaffinity labeling experiments, where the iodine atom was replaced with a diazirine group to create a reactive probe. This modification enabled researchers to identify novel binding partners of indole-containing compounds in complex biological systems, providing valuable insights into their mechanisms of action.

The synthetic accessibility of 3-iodo-6-methyl-1H-indole has also been improved through recent methodological advances. A 2023 publication in Organic Letters described an efficient, one-pot synthesis of this compound from commercially available starting materials, featuring a novel iodination protocol that minimizes byproduct formation. This development has significantly increased the compound's availability for research purposes, with several suppliers now offering it as a catalog item.

Looking forward, researchers anticipate that 3-iodo-6-methyl-1H-indole will continue to play an important role in drug discovery efforts. Its combination of synthetic versatility and biological relevance makes it particularly valuable for fragment-based drug design approaches. Current research directions include exploring its potential in targeted protein degradation strategies and as a core structure for the development of fluorescent probes for cellular imaging applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)